Trusted Resources: Community Center
A Guide to Understanding MPS I
MPS I is a mucopolysaccharide disease also called Hurler, Hurler-Scheie and Scheie syndrome. Hurler takes its name from Gertrude Hurler, the doctor who described a boy and girl with the condition in 1919. In 1962, Dr. Scheie, a consultant ophthalmologist, wrote about patients who were more mildly affected. Individuals who do not fit the severe or mild ends of the disease were said to have Hurler/Scheie.
The specific disease names have been replaced with the designations attenuated (diminished severity) and severe MPS I. MPS I has a wide range of symptoms that vary in severity and can be managed and treated with enzyme replacement therapies. There is no cure for MPS I.
BookmarkRelated Content
-
iPS-Derived Neural Stem Cells for Disease Modeling and Evaluation of Therapeutics for Mucopolysaccharidosis Type IIMucopolysaccharidosis type II (MPS II), ...
-
Real World Long-Term Outcomes in Patients With Mucopolysaccharidosis Type II: A Retrospective Cohort StudyWe investigated the decline of activitie...
-
Analysis of Cognitive Ability and Adaptive Behavior Assessment Tools Used in an Observational Study of Patients With...Mucopolysaccharidosis II (MPS II) is a r...
-
Lisa ToddLisa Todd lives in Albuquerque, NM, with...
-
Hunter Syndrome: OverviewHunter syndrome is a very rare, inherite...
-
Mucopolysaccharide Storage Disease Type I: Hurler, Hurler-Scheie, and Scheie Syndromeshttps://www.youtube.com/watch?v=en9M2P8S...
-
Stewart RustDr Rust completed his first degree at Le...
